Is the prescription of positive airway pressure (PAP) associated with lower all-cause mortality?
In this cohort study of 392 patients with obesity and severe obstructive sleep apnea with 11 years of follow-up, we found that prescription of PAP therapy was associated with a 62% lower risk of all-cause mortality compared with nonprescription of PAP, independent of major confounders.
Positive airway pressure therapy prescription is associated with lower all-cause mortality, beginning several years after PAP prescription.
The association of positive airway pressure (PAP) with reduced mortality in patients with obstructive sleep apnea (OSA) remains uncertain.
To investigate the association between PAP prescription and mortality.
Design, Setting, and Participants
This multicenter, population-based cohort study evaluated data from the Sleep Heart Health Study (SHHS), a long-term observational cohort study that included participants between 1995 and 1998, with a mean follow-up of 11.1 years. Analyses were performed in September 2018. Within the SHHS, we compared patients with obesity and severe OSA with (n = 81) and without (n = 311) prescription of PAP therapy, after matching patients from each group by age, sex, and apnea-hypopnea index.
Self-reported use of PAP.
Main Outcomes and Measures
Of 392 study participants, 316 (80.6%) were men, and mean (SD) age was 63.1 (11.0) years. Ninety-six deaths occurred; 12 among the prescribed-PAP group and 84 among the nonprescribed-PAP group, yielding crude incidence rates of 12.8 vs 24.7 deaths per 1000 person-years. In Cox multivariate analysis, the hazard ratio (HR) of all-cause mortality for prescribed PAP therapy was 0.38 (95% CI, 0.18-0.81). After propensity matching, the HR of all-cause mortality for prescribed PAP therapy was 0.58 (95% CI, 0.35-0.96). According to survival curves, the difference in mortality appears 6 to 7 years after initiation of PAP therapy.
Conclusions and Relevance
Positive airway pressure prescription is associated with reduced all-cause mortality, and this association appears several years after PAP initiation. If replicated, these findings may have strong clinical implications.
Lisan Q, Van Sloten T, Marques Vidal P, Haba Rubio J, Heinzer R, Empana JP. Association of Positive Airway Pressure Prescription With Mortality in Patients With Obesity and Severe Obstructive Sleep Apnea: The Sleep Heart Health Study. JAMA Otolaryngol Head Neck Surg. Published online April 11, 2019145(6):509–515. doi:10.1001/jamaoto.2019.0281
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: